Serviceeinschränkungen vom 12.-22.02.2026 - weitere Infos auf der UB-Homepage
American Psychological Association 6th edition

García-Mayor RV, Álvarez-Vázquez P, Fluiters E, Valverde D, & Andrade A. (2019). Long-term remission following antithyroid drug withdrawal in patients with Graves’ hyperthyroidism: parameters with prognostic value. Endocrine, 63(2), 316-316. https://doi.org/10.1007/s12020-018-1785-z

ISO-690 (author-date, English)

GARCÍA-MAYOR RV, ÁLVAREZ-VÁZQUEZ P, FLUITERS E, VALVERDE D und ANDRADE A, 2019. Long-term remission following antithyroid drug withdrawal in patients with Graves’ hyperthyroidism: parameters with prognostic value. Endocrine. 1 Februar 2019. Vol. 63, no. 2, p. 316-316. DOI 10.1007/s12020-018-1785-z.

Modern Language Association 9th edition

García-Mayor RV, Álvarez-Vázquez P, Fluiters E, Valverde D, und Andrade A. „Long-Term Remission Following Antithyroid Drug Withdrawal in Patients With Graves’ Hyperthyroidism: Parameters With Prognostic Value.“. Endocrine, Bd. 63, Nr. 2, Februar 2019, S. 316-, https://doi.org/10.1007/s12020-018-1785-z.

Mohr Siebeck - Recht (Deutsch - Österreich)

García-Mayor RV/Álvarez-Vázquez P/Fluiters E/Valverde D/Andrade A: Long-term remission following antithyroid drug withdrawal in patients with Graves’ hyperthyroidism: parameters with prognostic value., Endocrine 2019, 316-316.

Emerald - Harvard

García-Mayor RV, Álvarez-Vázquez P, Fluiters E, Valverde D und Andrade A. (2019), „Long-term remission following antithyroid drug withdrawal in patients with Graves’ hyperthyroidism: parameters with prognostic value.“, Endocrine, Vol. 63 No. 2, S. 316-316.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.